Form 8-K Merck & Co., Inc. For: Oct 27

Go back to Form 8-K Merck & Co., Inc. For: Oct 27

Merck (MRK) PT Lowered to $69 at Leerink Partners

October 30, 2017 7:49 AM EDT

Leerink Partners lowered its price target on Merck (NYSE: MRK) to $69.00 (from $70.00) while maintaining a Market Perform rating following results

Analyst Seamus Fernandez said the majority of the bottom-line beat came from other income and a lower-than-anticipated tax rate.

... More